Objectives: The objective of this study was to evaluate in a multicentre survey the analytical performance of the Check-Direct CPEw assay (CDCPE), a multiplex PCR assay for the detection of carbapenemase-producing Enterobacteriaceae (CPE), directly from rectal swabs.
Introduction
The accurate and timely detection of carbapenemase-producing Enterobacteriaceae (CPE) is crucial for appropriate patient management and for the rapid implementation of infection control measures. 1 The current process for detecting CPE in clinical samples is usually performed using selective cultures 2, 3 and may require up to 72 h for a result. Different molecular assays have been developed to identify the resistance genes from bacterial colonies 4, 5 and others directly on clinical samples. 6, 7 The Check-Direct CPE w assay (CDCPE; Check-Points, Wageningen, The Netherlands) is a commercial multiplex real-time PCR test that targets carbapenemases and has been recently evaluated on faecal specimens spiked with carbapenemase-producing organisms. 8 Nevertheless, most of these methods have rarely been validated in large multicentre clinical studies. We aimed to evaluate the analytical performance of CDCPE directly from rectal swabs in the clinical setting of a multicentre survey in Belgium. 
Patients and methods

Study population and screening procedures
Four acute-care hospitals located nationwide, selected for the epidemiological diversity of CPE prevalence and of carbapenemases that had previously been observed, 9 were asked to prospectively collect 100 nonduplicate rectal swabs (ESwab TM in 1 mL of Amies liquid; Copan, Brescia, Italy) between November 2013 and April 2014. All adult patients hospitalized in high-risk wards defined on a local basis (i.e. the ICU in two hospitals and the geriatric unit in two hospitals) or all adult patients known as having previously been colonized by a CPE strain were eligible upon admission. The study protocol was approved by the ethics committees of the participating centres (approval number B03920131823, issued on 13 October 2013).
Microbiological culture at local laboratories
Rectal swabs were cultured on a chromID w CARBA agar plate (CCAR) and on a chromID w OXA-48 agar plate (COXA; bioMé rieux, Marcy-l'É toile, France) incubated in the ambient atmosphere at 358C for 18-24 h. The macroscopic presence of faecal material (a yellow/brown-stained swab) was recorded as a quality indicator of the specimen. Growing colonies were identified at each laboratory according to their local procedures. No additional work-up was done on non-Enterobacteriaceae isolates. All Enterobacteriaceae isolates and the left-over anonymized swabs were stored at -208C until transfer in a batch to the central laboratory.
Characterization of isolates and CDCPE at the central laboratory
All stored isolates were identified by MALDI-TOF MS using a microflex LT (Bruker Daltonics, Leipzig, Germany), and the carbapenemase-encoding genes were identified by multiplex PCR targeting bla OXA-48 , bla KPC , bla VIM , bla IMP and bla NDM . 4 CDCPE is a multiplex real-time PCR using probes labelled with four different fluorophores for the detection of bla KPC , bla OXA-48 , bla VIM/NDM and an internal extraction/inhibition control. With the kit tested here, bla VIM and bla NDM are detected by the same fluorochrome (VIC) and are not distinguishable. 8 The nucleic acid extraction of the rectal swabs was performed using NucliSENS w easyMAG w (bioMérieux). Briefly, 200 mL of the ESwab TM transport medium was mixed with 200 mL of the NucliSENSw Lysis Buffer, vortexed for 10 min and centrifuged for 2 min at 13 000 rpm. A volume of 100 mL of the supernatant was transferred to a 2 mL NucliSENSw Lysis Buffer tube for an additional 10 min offboard lysis at room temperature. The sample's nucleic acids were purified on the easyMAG w using the specific A v1.0.2 program along with 5 mL of the internal control (IC) provided (Check-Points) and were eluted in 110 mL of buffer. The amplification was run on a LightCycler w 480 II platform (Roche, Brussels, Belgium) after a colour compensation process using a four-colour compensation set (Check-Points). Amplification curves were analysed with the 'High Confidence' option (LightCycler w 480 v1.5 software) as recommended by the manufacturer. A PCR-negative control containing only the IC and lysis buffer was used as Ct value reference for the IC (CtIC). A sample was considered positive for the presence of a carbapenemase gene whenever a Ct ,45 was detected for this gene. A carbapenemase-negative result for a sample was validated when the CtIC of the sample was not .3-fold higher than the CtIC of the extraction control; otherwise the sample was considered to have been inhibited and was retested. The time to results (TTR) was 3.5 h (1 h extraction and 2.5 h RT-PCR).
Data analysis and resolution of discrepancies
The analytical performance of CDCPE was evaluated by comparing the results obtained with CDCPE with those of molecularly confirmed CPE isolates growing on selective culture, which was taken as the reference gold standard. A sample was labelled as a true negative when CDCPE yielded a negative result and the culture did not grow any CPE isolate confirmed by molecular testing. A true-positive sample yielded a positive carbapenemase signal on CDCPE that was identical to that of the gene identified by multiplex PCR on CPE isolates grown by culture. A sample was considered to give a false-positive result when a carbapenemase-encoding gene detected in the specimen by CDCPE could not be confirmed by multiplex PCR on growing Enterobacteriaceae colonies or when no Enterobacteriaceae isolate could be recovered on selective culture. For these discrepancies, the microbiological history was reviewed, seeking the colonization of other clinical specimens from the same patient by a carbapenemase-producing organism (Enterobacteriaceae, Pseudomonas spp. or Acinetobacter spp.) within the previous year.
Results and discussion
Carbapenemase detection results from CDCPE and from Enterobacteriaceae isolates recovered from selective culture Huang et al. This observation confirms the importance of using one specific selective medium for the recovery of OXA-48 producers. 10 The status of five specimens (1.4%) giving invalid (inhibited) results on first testing with CDCPE was resolved (all negative results) after subsequent testing. Overall, a concordance of 94.7% (373/394) was observed between the culture and CDCPE results. When compared with the selective culture, the sensitivity, specificity and negative predictive value of CDCPE were 100%, 94% and 100%, respectively. The highly variable positive predictive value between participating centres (0% for centres C1 and C3, 25% for C2 and 70% for C4) could have resulted from the low number of positive samples found. Tenover et al.
11 recently showed excellent performance of the Xpert MDRO Assay (Cepheid, Sunnyvale, CA, USA), an easy-to-use (extraction step included), rapid multiplex PCR-based method, directly on faecal samples targeting important carbapenemases (VIM, IMP, NDM and KPC) but not OXA-48, which is widespread in European countries. 12 Regarding the 21 (5.3%) false-positive results (Table 2) , the microbiological history review showed a previous carriage of carbapenemase-producing bacteria in five patients, with one sample yielding a strong VIM/NDM signal (Ct¼22.17) and the growth of Pseudomonas aeruginosa colonies (highly suggestive of VIM production). The other nine VIM/NDM-positive samples all showed a lower signal (Ct.36) and no growth of Gram-negative bacilli on selective culture. We believe that the lack of differentiation between VIM and NDM in the present study may be epidemiologically important and that this pitfall may be circumvented either by using another version of CDCPE adapted to other platforms (CFX96, Bio-Rad or BD MAX system, BD Molecular Diagnostics) or by retesting VIM/NDM-positive samples using the TaqMan system. In addition, 6/9 rectal swabs that were OXA-48 positive using CDCPE but were not confirmed by culture may indeed correspond to true-positive results as they were collected in a centre in which a longstanding major outbreak due to OXA-48-producing Klebsiella pneumoniae was occurring. However, the OXA-48-like gene that was detected may also be carried by other organisms from the intestinal microbiota (e.g. Shewanella spp.) that are not routinely cultured. 13 The major strength of our study was that the evaluation was performed in a multicentre setting using a standardized methodology for sampling and culture-processing, together with centralized testing to confirm CPE in the isolates recovered and to detect CPE directly in rectal samples using CDCPE. Additionally, CDCPE showed a shorter TTR (3.5 h) compared with culture (24 h) but required a preliminary extraction step to avoid inhibition. The processing time might be further shortened using a simple lysis method as suggested by Vasoo et al.
14 Nevertheless, the potential benefit of a shorter TTR for infection control management could not be evaluated in our study and remains to be demonstrated.
We acknowledge that this study suffers from several limitations. First, we could not exclude that the negative results on culture and/or on PCR were possibly the consequence of a poor Huang et al.
quality of sampling (no macroscopic staining was visualized), which was observed in 20% (77/394) of the specimens. Indeed, lower rates of CPE detection were observed among the 77 'poor quality' swabs (5% with CDCPE and 1% with culture) compared with the 317 samples showing the macroscopic presence of faeces (11% with CDCPE and 5% with culture), although these differences did not reach statistical significance (P ¼ 0.14 for CDCPE and P ¼ 0.15 for culture). This observation highlights the difficulty of obtaining appropriate specimens by rectal swabbing in routine clinical practice, which can seriously compromise the efficacy of targeted screening. Second, selective culture considered as the reference method may lack sensitivity for the recovery of CPE (a low level of resistance being expressed for some carbapenemases, especially with a low inoculum) 3, 10 and thus negatively affect the positive predictive value of CDCPE. The fact that the majority (18/21) of the PCR-positive results with higher Ct values (.30) could not be confirmed by culture suggests that the assay may indeed be more sensitive than culture for detecting CPE at a very low inoculum. Third, the ability of CDCPE to efficiently detect carbapenemases other than OXA-48 in clinical samples could not be extensively demonstrated in the current study because of the very small number of CPE isolates detected.
In conclusion, CDCPE proved highly accurate in the identification of CPE carriers, with a shorter turnaround time than for culture, in a setting of a low overall prevalence of CPE mostly dominated by OXA-48 CPE. With a negative predictive value of 100%, CDCPE could be a valuable screening tool to exclude faecal carriers of CPE in an outbreak setting. Further investigation by retesting on follow-up samples from carbapenemase PCR-positive, culturenegative patients should be carried out to confirm the true positivity of these signals and could better describe the dynamics of carbapenemase carriage.
